Mibefradil is a calcium channel blocker of the tetralol class that was historically indicated for the treatment of hypertension and chronic angina pectoris. Although it was withdrawn from clinical use… Read more
Mibefradil is a calcium channel blocker of the tetralol class that was historically indicated for the treatment of hypertension and chronic angina pectoris. Although it was withdrawn from clinical use due to safety concerns, the compound remains a valuable subject in pharmaceutical research for exploring ion channel mechanisms. Our catalogue provides essential reference standards for Mibefradil, including the active pharmaceutical ingredient, identified impurities, and stable isotope-labelled compounds. These materials are critical for laboratories conducting rigorous analytical testing, such as impurity profiling and metabolic studies. By utilizing these high-quality reference standards, researchers can perform accurate method validation and maintain robust quality control, ensuring precision in quantitative assays and the consistent evaluation of chemical composition in pharmaceutical development and scientific analysis.